Barney S. Graham | |
---|---|
Born | 1953 Kansas City, Missouri |
Spouse(s) | Cynthia Turner-Graham, M.D. |
Children | 3 |
Academic background | |
Education | B.S., biology, Rice University M.D., 1979, University of Kansas School of Medicine Ph.D., Microbiology and Immunology, 1991, Vanderbilt University |
Academic work | |
Institutions | Vaccine Research Center National Institutes of Health Vanderbilt University |
Barney S. Graham is an American immunologist,virologist,and clinical trials physician.
He is currently Professor of Medicine and Microbiology,Biochemistry,&Immunology and Senior Advisor for Global Health Equity [1] at Morehouse School of Medicine in Atlanta. He is the former [2] deputy director of the Vaccine Research Center (VRC),part of the National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH). During his tenure at the VRC,Graham also served as chief of the Viral Pathogenesis Laboratory.
He was elected a member of the National Academy of Sciences in 2022. [3]
Graham was born in Kansas City,Missouri,the first son of Barney Dan Graham,DDS and Carol Ann Hastings and spent most of his childhood in Olathe,Kansas through early high school. The family moved to a farm near Paola,Kansas,where he graduated from Paola High School as valedictorian in 1971. He attended college at Rice University and graduated magna cum laude in 1975 with a BA degree in biology. After earning his medical degree from the University of Kansas School of Medicine in 1979,Graham continued his training at Vanderbilt University where he completed his internship,residency,consecutive chief residencies at Nashville General Hospital and Vanderbilt University Medical Center,followed by infectious diseases fellowship,and a PhD in Microbiology and Immunology. [4]
By 1982,Graham was appointed chief resident at Nashville General Hospital, [5] where he treated Tennessee's first AIDS patient. [6] Following this,he was named to a chief residency at Vanderbilt University Medical Center, [7] where he led one of the first human trials of candidate AIDS vaccines. [8] The results of the trial found that the two experimental AIDS vaccines proved to yield the best immune response in patients. [9] During his time at Vanderbilt,Graham was working simultaneously on his Ph.D. in microbiology. [7]
Graham was elected a member of the American Society for Clinical Investigation in 1996. [10] In 2000,the National Institutes of Health (NIH) recruited him to create a vaccine evaluation clinic (Vaccine Research Center),but he insisted on maintaining a research laboratory to focus on vaccines for three categories of respiratory viruses. [6] During the 2015–2016 Zika virus epidemic,Graham and Ted Pierson,chief of the Laboratory of Viral Diseases,collaborated to create a vaccine intended to prevent the Zika virus. Moving from inception to manufacturing in just three months,they began a Phase 2 clinical trial in March 2017 to measure its effectiveness. In recognition of their efforts,they were finalists for the 2018 Promising Innovations Medal. [11] In 2021 he received the Albany Medical Center Prize. [12] In 2022 he was awarded the John J. Carty Award for the Advancement of Science of the NAS. [13] Graham was included in Time 2024 most influential people on health list. [14]
By 2017,working alongside Jason McLellan,a structural biologist,they discovered that "adding two prolines to a key joint of a vaccine's spike protein could stabilize the structure's prefusion shape" (patent WO2018081318A1). Later,this method would be applied to the COVID-19 vaccine. [15] During the COVID-19 pandemic,Graham's laboratory partnered with Moderna to develop vaccine technology. He was a member of the research team that designed a spike protein to combat the virus.
His research found that some virus proteins change shape after they break into a person's cells,leading to the design of a better vaccine against respiratory syncytial virus. [16] [17] Graham was named in the 2024 Time 100 most influential people in health list. [18]
Graham is married to Cynthia Turner-Graham,also a physician. She specializes in psychiatry. [19] They have three adult children.
The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH),an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand,treat,and prevent infectious,immunologic,and allergic diseases.
Donald Pinkston Francis is an American physician and epidemiologist who worked on the Ebola outbreak in Africa in the late 1970s,and as an HIV/AIDS researcher. He retired from the U.S. Public Health Service in 1992,after 21 years of service. He lives in San Francisco,California.
The University of Kansas Medical Center,commonly referred to as KU Med or KUMC,is a medical campus for the University of Kansas. KU Med houses the university's schools of medicine,nursing,and health professions,with the primary health science campus in Kansas City,Kansas. Other campuses are located in Wichita and Salina,Kansas,and is connected with the University of Kansas Health System.
Robert Ray Redfield Jr. is an American virologist who served as the Director of the U.S. Centers for Disease Control and Prevention and the Administrator of the Agency for Toxic Substances and Disease Registry from 2018 to 2021.
The Vaccine Research Center (VRC),is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID),part of the National Institutes of Health (NIH),US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
Zika virus is a member of the virus family Flaviviridae. It is spread by daytime-active Aedes mosquitoes,such as A. aegypti and A. albopictus. Its name comes from the Ziika Forest of Uganda,where the virus was first isolated in 1947. Zika virus shares a genus with the dengue,yellow fever,Japanese encephalitis,and West Nile viruses. Since the 1950s,it has been known to occur within a narrow equatorial belt from Africa to Asia. From 2007 to 2016,the virus spread eastward,across the Pacific Ocean to the Americas,leading to the 2015–2016 Zika virus epidemic.
The University of Kansas School of Medicine is a public medical school located on the University of Kansas Medical Center campuses in Kansas City,Kansas,and also Salina,Kansas,and Wichita,Kansas. The Kansas City campus is co-located with the independent University of Kansas Health System,and they are commonly known collectively as KU Med.
Bernard Moss is a virologist at the National Institute of Allergy and Infectious Diseases,part of the United States National Institutes of Health. He is the Chief of the NIAID Laboratory of Viral Diseases and of the NIAID Genetic Engineering Section. He is known for his work on poxviruses.
Jay A. Levy is an American AIDS and cancer research physician. He is a professor of medicine with specialties in virology and immunology at the University of California,San Francisco (UCSF).
Julie E. Ledgerwood is an American allergist and immunologist,who is the chief medical officer and chief of the Clinical Trials Program at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID),part of the National Institutes of Health in Bethesda,Maryland. She is a Doctor of Osteopathic Medicine.
Gary J. Nabel is an American virologist and immunologist who is President and chief executive officer of ModeX Therapeutics in Natick,Massachusetts. He was the founding director of Vaccine Research Center at the National Institute of Allergy and Infectious Diseases.
A Zika virus vaccine is designed to prevent the symptoms and complications of Zika virus infection in humans. As Zika virus infection of pregnant women may result in congenital defects in the newborn,the vaccine will attempt to protect against congenital Zika syndrome during the current or any future outbreak. As of April 2019,no vaccines have been approved for clinical use,however a number of vaccines are currently in clinical trials. The goal of a Zika virus vaccine is to produce specific antibodies against the Zika virus to prevent infection and severe disease. The challenges in developing a safe and effective vaccine include limiting side effects such as Guillain-Barrésyndrome,a potential consequence of Zika virus infection. Additionally,as dengue virus is closely related to Zika virus,the vaccine needs to minimize the possibility of antibody-dependent enhancement of dengue virus infection.
Nelson L. Michael is an American infectious disease researcher. He has served for nearly 30 years in the United States Army and been directly involved with significant advancements in understanding the pathology of and vaccine development for diseases like HIV,Zika,Ebola and more. Much of his career has been spent at the Walter Reed Army Institute of Research.
James Earl Crowe Jr. is an American immunologist and pediatrician as well as Professor of Pediatrics and Pathology,Microbiology,and Immunology at Vanderbilt University Medical Center.
Brian R. Murphy is an American virologist and former co-chief of the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Disease.
Dan Hung Barouch is an American physician,immunologist,and virologist. He is known for his work on the pathogenesis and immunology of viral infections and the development of vaccine strategies for global infectious diseases.
Kizzmekia "Kizzy" Shanta Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.
Vanessa M. Hirsch is a Canadian-American veterinary pathologist and scientist. She is a senior investigator and chief of the nonhuman primate virology section at the National Institute of Allergy and Infectious Diseases. Hirsch researches AIDS pathogenesis,the evolution and origins of primate lentiviruses,and HIV vaccine development.
Heinz (Heinrich) Ulrich Feldmann is a German-American virologist who currently serves as the chief of the laboratory of virology at Rocky Mountain Laboratories,NIAID and heads the Disease Modelling and Transmission section. His research focuses on highly pathogenic viruses that require strict biocontainment,including those that cause viral hemorrhagic fever such as Ebola and Lassa. He has been responsible for the development of timely viral countermeasures including the rVSV-ZEBOV vaccine (Ervebro),development of vaccines and drugs against SARS-CoV-2,and epidemiology of SARS-CoV.
John R. Mascola is an American physician-scientist,immunologist and infectious disease specialist. He was the director of the Vaccine Research Center (VRC),part of the National Institute of Allergy and Infectious Diseases (NIAID),National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci,director of NIAID,on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ModeX Therapeutics.
Barney S. Graham publications indexed by Google Scholar